⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30428883 | 1.00 | — | — | |
| Bromide SCHEMBL5757886 | 0.97 | — | — | |
| Hydrochloric Acid SCHEMBL4126368 | 0.97 | — | — | |
| Pyridine SCHEMBL27606048 | 0.85 | NOS3 (0.41) | — | |
| SCHEMBL4024197 | 0.83 | TDO2 (0.46) | — | |
| SCHEMBL1091572 | 0.80 | PIK3CD (0.57) | — | |
| SCHEMBL29078057 | 0.79 | MEN1 (0.60) | — | |
| SCHEMBL29457388 | 0.79 | MEN1 (0.60) | — | |
| SCHEMBL29966515 | 0.77 | — | — | |
| SCHEMBL882102 | 0.77 | FEN1 (0.46) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2580 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119432148-A | Perovskite ink, perovskite film and battery device | 云南大学 | 2025-02-14 | — | — | CN | claimed |
| CN-119384207-A | Perovskite precursor solution, perovskite film, preparation method of perovskite precursor solution and perovskite battery | 天合光能股份有限公司 | 2025-01-28 | — | — | CN | claimed |
| CN-118994106-A | Preparation method of diastereoisomer of lebol Lei Sheng | 福安药业集团重庆礼邦药物开发有限公司 | 2024-11-22 | — | — | CN | claimed |
| CN-118561838-A | Preparation method of 5-fluoro-1- (2-fluorophenyl) -1H-pyrazolone [3,4-B ] pyridine-3-carbonitrile | 合肥菁科生物科技有限公司 | 2024-08-30 | — | — | CN | claimed |
| CN-117654560-B | Method for continuously preparing nitro compound by oxidizing amino | 安徽泽升科技股份有限公司 | 2024-06-04 | — | — | CN | claimed |
| CN-117924347-A | Preparation method of monosulfur organosilane coupling agent | 江西宏柏新材料股份有限公司 | 2024-04-26 | — | — | CN | claimed |
| CN-117654560-A | Method for continuously preparing nitro compound by oxidizing amino | 安徽泽升科技股份有限公司 | 2024-03-08 | — | — | CN | claimed |
| CN-116924975-A | Preparation method of 2-amino-5-fluoropyridine | 中节能万润股份有限公司 | 2023-10-24 | — | — | CN | claimed |
| US-20220402875-A1 | S1P3 Antagonists | TEVA PHARMACEUTICAL INDUSTRIES, LTD. (IL) | 2022-12-22 | — | — | US | claimed |
| EP-3484865-B1 | SOMATOSTATIN MODULATORS AND USES THEREOF | CRINETICS PHARMACEUTICALS INC (US) | 2022-09-14 | — | — | EP | claimed |
| EP-1646621-A2 | NOVEL AZAHETEROCYCLIC AMIDES USEFUL FOR TREATING PAIN | Abbott Laboratories (US) | 2006-04-19 | — | — | EP | claimed |
| US-6949562-B2 | Heterocyclic compounds as ligands of the GABAA receptor | NEUROGEN CORPORATION (US) | 2005-09-27 | — | — | US | claimed |
| US-20050080095-A1 | administering a therapeuitcally effective amount of 3'-(trifluoromethyl)-N-{4-[(trifluoromethyl)sulfonyl]phenyl}-3,6-dihydro-2H-1,2'-bipyridine-4-carboxamide; antagonists of vanilloid receptor subtype I | ABBVIE INC. | 2005-04-14 | — | — | US | claimed |
| US-20050065143-A1 | Pyridazine derivatives and their use as therapeutic agents | XENON PHARMACEUTICALS INC. (CA) | 2005-03-24 | — | — | US | claimed |
| WO-2005007642-A2 | NOVEL AZAHETEROCYCLIC AMIDES USEFUL FOR TREATING PAIN | ABBOTT LABORATORIES (US) | 2005-01-27 | — | — | WO | claimed |
| US-20040110778-A1 | Heterocyclic compounds as ligands of the GABAA receptor | YOHANNES DANIEL (US) | 2004-06-10 | — | — | US | claimed |
| EP-1422218-A1 | ANTIVIRAL AGENT | SHIONOGI & CO., LTD. (JP) | 2004-05-26 | — | — | EP | claimed |
| EP-1325006-A2 | HETEROCYCLIC COMPOUNDS AS LIGANDS OF THE GABA A? RECEPTOR | NEUROGEN CORPORATION (US) | 2003-07-09 | — | — | EP | claimed |
| US-20030105081-A1 | Heterocyclic compounds as ligands of the GABAA receptor | PFIZER INC | 2003-06-05 | — | — | US | claimed |
| WO-2002012442-A2 | HETEROCYCLIC COMPOUNDS AS LIGANDS OF THE GABAA RECEPTOR | NEUROGEN CORPORATION (US) | 2002-02-14 | — | — | WO | claimed |